Summary:
Summary Statement of Deficiencies D0000 A Clinical Laboratory Improvement Amendments (CLIA) recertification survey was completed on April 28, 2021. The laboratory was not in compliance with applicable CLIA requirements found at 42 CFR 493.1 through 42 CFR 493.1780. The following deficiencies were cited: D1001 CERTIFICATE OF WAIVER TESTS CFR(s): 493.15(e) Laboratories eligible for a certificate of waiver must-- (1) Follow manufacturers' instructions for performing the test; and (2) Meet the requirements in subpart B, Certificate of Waiver, of this part. This STANDARD is not met as evidenced by: Based on lack of quality control (QC) logs, observation during the laboratory tour, review of laboratory test package inserts, and staff interview, the laboratory failed to follow current manufacturer's instructions for all waived tests performed by the laboratory as required. Findings include: 1. Review of waived test package inserts and observation during the laboratory tour on 04/28/21 at approximately 11:00 a.m. revealed there were no required QC logs available at the time of survey for the following waived tests: Urine Human Chorionic Gonadotropin (hCG)(Henry Schein) and Microhematocrit (Clay Adams Readacrit) for 2019, 2020 or 2021 thus far. 2. An interview with staff #3 (CMS 209) in the lab at approximately 11:10 a.m. on 104/28 /2021 confirmed the lack of QC documents for the aforementioned waived tests for 2019, 2020, & 2021 thus far. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --